Research
Intensive blood pressure therapy did not cut cardiovascular events in adults with diabetes
The Brief
- An intensive blood pressure-lowering strategy targeting systolic pressure below 120 mm Hg did not significantly reduce major cardiovascular events in adults with type 2 diabetes.
- The endpoints studied included cardiovascular death, stroke and heart attack, according to the report.
- The study addresses adults with type 2 diabetes who are at increased risk of cardiovascular events.
Why it matters
The result challenges the assumption that more aggressive blood pressure targets automatically prevent cardiovascular events in this high-risk group, which bears on how clinicians and guideline writers set treatment goals for patients with diabetes.
Who’s affected
- clinicians treating adults with type 2 diabetes
- researchers in cardiovascular and diabetes medicine
- patients with type 2 diabetes and hypertension
Intensive blood pressure-lowering treatment to reduce systolic pressure below 120 mm Hg in adults with type 2 diabetes, who are at increased risk of cardiovascular events, did not significantly reduce the incidence of cardiovascular death, stroke, heart attack or other…
Timeline
Medical Xpress reports that intensive blood pressure therapy did not significantly reduce cardiovascular events in adults with diabetes
Medical Xpress - latest medical and health news stories
Intensive blood pressure therapy did not cut cardiovascular events in adults with diabetes